注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
代號 | 交易所 | 貨幣 | ||
---|---|---|---|---|
IPH | 巴黎 | EUR | 即時 | |
IPHp | BATS Europe | EUR | 延遲 | |
IPHA | NASDAQ | USD | 即時 | |
IPHYF | OTC Markets | USD | 延遲 | |
IPH | TradeGate | EUR | 延遲 |
Innate Pharma SA是一家主要開髮用於治療癌症和炎症性疾病的藥物的法國生物製藥公司。該公司確定候選藥物並對其進行表徵,選擇適應症並管理產品的臨床前和臨床開發。該公司主要從事研發新的治療解決方案和單克隆抗體,用於治療癌症、傳染病和慢性炎症性疾病。該公司開發了兩類免疫療法:免疫調節劑和細胞毒性抗體。該公司與百時美施貴寶合作進行一期癌症抗體計劃,並與諾和諾德合作進行兩項炎症治療抗體計劃。該公司通過anti-NKG2A抗體,一種諾和諾德的腫瘤學二期免疫檢查點抑製劑,來開展業務。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Mailys Ferrere | 59 | 2017 | Member of Supervisory Board |
Gilles Brisson | 72 | 2007 | Independent Member of Supervisory Board |
Irina Staatz-Granzer | 64 | 2009 | Independent Chairwoman of Supervisory Board |
Ruslan Medzhitov | - | 2018 | Strategic Advisory Board Member |
Tanguy Seiwert | - | 2018 | Strategic Advisory Board Member |
Mario Sznol | 66 | 2018 | Strategic Advisory Board Member |
Aurelien Marabelle | - | 2018 | Strategic Advisory Board Member |
Olivier Martinez | 54 | 2010 | Member of Supervisory Board |
Sebastian Amigorena | - | 2018 | Strategic Advisory Board Member |
Jean-Yves Blay | 62 | 2017 | Independent Member of Supervisory Board |
Veronique Chabernaud | 63 | 2015 | Independent Member of Supervisory Board |
Miriam Merad | - | 2018 | Chairman of Strategic Advisory Board |
Pascale Boissel | 58 | 2020 | Independent Vice Chairperson of the Supervisory Board |
Sally L. Bennett | 52 | 2022 | Independent Supervisory Board Member |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核